Researcher.Life Logo

JHEP Reports : Impact Factor & More

eISSN: 2589-5559pISSN: 2589-5559
JournalOpen Access

Key Metrics

CiteScore
8.1
Impact Factor
5 - 10
SNIP
2.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on JHEP Reports

JHEP Reports Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
Article Processing ChargesEUR 2000
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEASL: European Association for the Study of the Liver
FrequencyBi-monthly
Publication Start Year2019
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in JHEP Reports ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JHEP Reports

Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysis.
  • 12 May 2026
  • JHEP reports : innovation in hepatology
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.
  • 12 May 2026
  • JHEP reports : innovation in hepatology
Actin-specific smooth muscle antibodies in juvenile autoimmune liver diseases: Heterogenous diagnostic accuracy across varying test systems.
  • 9 May 2026
  • JHEP reports : innovation in hepatology
Comment on: Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis - Circular definition of CVRM comorbidities undermines the validity of core subgroup comparisons.
  • 9 May 2026
  • JHEP reports : innovation in hepatology
Epithelial MLCK deficiency alleviates alcohol-associated liver disease via dendritic-Th17 cell axis.
  • 8 May 2026
  • JHEP reports : innovation in hepatology
Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.
  • 8 May 2026
  • JHEP reports : innovation in hepatology
Second-Line TKI after First-Line Immunotherapy-based Treatment in Advanced HCC: Reconstructed IPD Meta-analysis.
  • 12 May 2026
  • JHEP reports : innovation in hepatology
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitis.
  • 12 May 2026
  • JHEP reports : innovation in hepatology
Actin-specific smooth muscle antibodies in juvenile autoimmune liver diseases: Heterogenous diagnostic accuracy across varying test systems.
  • 9 May 2026
  • JHEP reports : innovation in hepatology
Comment on: Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitis - Circular definition of CVRM comorbidities undermines the validity of core subgroup comparisons.
  • 9 May 2026
  • JHEP reports : innovation in hepatology
Epithelial MLCK deficiency alleviates alcohol-associated liver disease via dendritic-Th17 cell axis.
  • 8 May 2026
  • JHEP reports : innovation in hepatology
Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.
  • 8 May 2026
  • JHEP reports : innovation in hepatology

FAQs on JHEP Reports